1 Min Read
March 2 (Reuters) - Diplomat Pharmacy Inc
* Diplomat dispensing Revlimid for multiple myeloma maintenance therapy following autologous hematopoietic stem cell transplant (auto-HSCT) Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.